JPRN-jRCT1080220042未知4 期
Post-marketing clinical study of Ogamma 100 in patients with adult T-cell leukemia (ATL)
适应症
试验速览
- 阶段
- 4 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •Patients with ATL aged between 20 and 79 years, inclusive, at time of consent
排除标准
- 未提供
研究者
相似试验
未知
4 期
Post-marketing clinical study of Ogamma 100 in patients with mycosis fungoidesMycosis fungoidesJPRN-jRCT1080220041Otsuka Pharmaceutical Co., Ltd.
未知
4 期
Postmarketing clinical study on AO-128Impaired glucose toleranceJPRN-jRCT1080220971Takeda Pharmaceutical Company Limited197
已完成
不适用
A post market clinical follow-up study with the Optimys Stem, with initial RSA analysisHip ArthroplastyHip replacement10023213NL-OMON47653Stichting SCORE150
未知
4 期
Post-marketing Clinical Study of Onglyza TabletJPRN-jRCT1080222299Kyowa Hakko Kirin Co., Ltd.
撤回
不适用
Post market clinical follow-up study for the Pamira ICD lead family.cardiac arrhythmias10007521NL-OMON56034BIOTRONIK SE & Co.KG30